CEO Jeffrey Robins resigns; William Hayde appointed as CEO and Chairman

Nu-Med Plus, Inc.

Jeffrey L. Robins resigned as President, CEO, Director and Chairman on Sept 12, 2022; Dr. Brett J. Earl resigned as director.
William Hayde appointed as President, CEO, Director and Chairman; granted an Employment Agreement.
Company authorized issuance of 2,000,000 restricted shares to Hayde Family Revocable Trust for past services.
Keith L. Merrell, CFO, entered new Employment Agreement replacing the prior 2018 agreement.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Jeffrey L. Robins

President, Chief Executive Officer, Director and Chairman of the Board

NUMD · Nu-Med Plus, Inc.

Effective: 2022-09-12
Successor: William Hayde
Filed: September 13, 2022, 7:59 PM ET

On September 12, 2022, Jeffrey L. Robins resigned as President, Chief Executive Officer, Director and Chairman of the Board

Departed

Dr. Brett J. Earl

Director

NUMD · Nu-Med Plus, Inc.

Effective: 2022-09-12
Filed: September 13, 2022, 7:59 PM ET

and Dr. Brett J. Earl resigned as a director.

Appointed

William Hayde

President, Chief Executive Officer, Director and Chairman of the Board

NUMD · Nu-Med Plus, Inc.

Effective: 2022-09-12
Filed: September 13, 2022, 7:59 PM ET

The Corporation has appointed Mr. William Hayde as the President, Chief Executive Officer, Director and Chairman of the Board.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jeffrey L. Robins resigned as President, Chief Executive Officer, Director and Chairman of the Board at Nu-Med Plus, Inc..

Action: resigned
Role: President, Chief Executive Officer, Director and Chairman of the Board

Exact text from the filing

On September 12, 2022, Jeffrey L. Robins resigned as President, Chief Executive Officer, Director and Chairman of the Board

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. Brett J. Earl resigned as Director at Nu-Med Plus, Inc..

Action: resigned
Role: Director

Exact text from the filing

and Dr. Brett J. Earl resigned as a director.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

William Hayde was appointed as President, Chief Executive Officer, Director and Chairman of the Board at Nu-Med Plus, Inc..

Action: appointed
Role: President, Chief Executive Officer, Director and Chairman of the Board

Exact text from the filing

The Corporation has appointed Mr. William Hayde as the President, Chief Executive Officer, Director and Chairman of the Board.

View on SEC.gov

Nu-Med Plus, Inc. filing history →

Source: SEC EDGAR

accession 0001548123-22-000147

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.